Ferruginol suppresses survival signaling pathways in androgen-independent human prostate cancer cells

Biochimie

Volumn 90, Issue 6, 2008, Pages 843-854

  Bispo de Jesus, Marcelo ^a   Zambuzzi, Willian Fernando ^a   Ruela de Sousa, Roberta Regina ^a   Areche, Carlos ^b   Santos de Souza, Ana Carolina ^a   Aoyama, Hiroshi ^a   Schmeda Hirschmann, Guillermo ^b   Rodríguez, Jaime A ^b   Monteiro de Souza Brito, Alba Regina ^a   Peppelenbosch, Maikel P ^c   den Hertog, Jeroen ^d   de Paula, Eneida ^a   Ferreira, Carmen Veríssima ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDAD DE TALCA   (Chile)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Apoptosis; Ferruginol; Natural compound; Prostate cancer

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE; FERRUGINOL; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN;

ARTICLE; CANCER CELL; CELL CYCLE REGULATION; CELL DEATH; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROSTATE CANCER; TUMOR GROWTH;

BACTERIA (MICROORGANISMS); PODOCARPACEAE;

EID: 44449164361     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.01.011     Document Type: Article

References (49)

1. Moul J. Report from Durham. Prostate Cancer Prostatic Dis. 8 (2005) 1
2. Dawson N. New molecular targets in advanced prostate cancer. Expert Rev. Anticancer Ther. 6 (2006) 993-1002
3. Miranda M.A., Okamoto A.K., Ferreira C.V., Silva T.L., Granjeiro J.M., and Aoyama H. Differential effects of flavonoids on bovine kidney low molecular mass protein tyrosine phosphatase. J. Enzyme Inhib. Med. Chem. 21 (2006) 419-425
4. Freire A.G., Melo P.S., Haun M., Duran N., Aoyama H., and Ferreira C.V. Cytotoxic effect of the diterpene lactone dehydrocrotonin from Croton cajucara on human promyelocytic leukaemia cells. Planta Med. 69 (2003) 67-69
5. Ferreira C.V., Bos C.L., Versteeg H.H., Justo G.Z., Duran N., and Peppelenbosch M.P. Molecular mechanism of violacein-mediated human leukemia cell death. Blood 104 (2004) 1459-1464
6. Martins Cavagis A.D., Ferreira C.V., Versteeg H.H., Assis C.F., Bos C.L., Bleuming S.A., Diks S.H., Aoyama H., and Peppelenbosch M.P. Tetrahydroxyquinone induces apoptosis of leukemia cells through diminished survival signaling. Exp. Hematol. 34 (2006) 188-196
7. Kodach L.L., Bos C.L., Durán N., Peppelenbosch M.P., Ferreira C.V., and Hardwick J.C. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis 27 (2006) 508-516
8. de Souza A.C.S., Kodach L., Gadelha F.R., Bos C.L., Cavagis A.D., Aoyama H., Peppelenbosch M.P., and Ferreira C.V. A promising action of riboflavin as a mediator of leukaemia cell death. Apoptosis 11 (2006) 1761-1771
9. Sousa R.R.R., Souza A.C.S., Queiroz K.C., Peppelenbosch M.P., Ferreira C.V., and Aoyama H. Phosphoprotein levels, MAPK activities and NFkB expression are affected by fisetin. J. Enzyme Inhib. Med. Chem. 22 (2007) 439-444
10. de Souza Queiroz K.C., Zambuzzi W.F., Santos de Souza A.C., da Silva R.A., Machado D., Justo G.Z., Carvalho H.F., Peppelenbosch M.P., and Ferreira C.V. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours. Cancer Lett. 258 (2007) 126-134
11. Iwamoto M., Minami T., Tokuda H., Ohtsu H., and Tanaka R. Potential antitumor promoting diterpenoids from the stem bark of Thuja standishii. Planta Med. 69 (2003) 69-72
12. Becerra J., Flores C., Mena J., Aqueveque P., Alarcón J., Bittner M., Hernández V., Hoeneisen M., Ruiz E., and Silva M. Antifungal and antibacterial activity of diterpenes isolated from wood extractables of Chilean Podocarpaceae. Boletín de la Sociedad Chilena de Química 47 (2002) 151-157
13. Chang S., Chen P., Wang S., and Wu H. Antimite activity of essential oils and their constituents from Taiwania cryptomerioides. J. Med. Entomol. 38 (2001) 455-457
14. Ulubelen A., Birman H., Oksuz S., Topcu G., Kolak U., Barla A., and Voelter W. Cardioactive diterpenes from the roots of Salvia eriophora. Planta Med. 68 (2002) 818-821
15. Ono M., Yamamoto M., Masuoka C., Ito Y., Yamashita M., and Nohara T. Diterpenes from the fruits of Vitex rotundifolia. J. Nat. Prod. 62 (1999) 1532-1537
16. Clarkson C., Campbell W.E., and Smith P. In vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (devil's claw). Planta Med. 69 (2003) 720-724
17. Rodriguez J.A., Theoduloz C., Yanez T., Becerra J., and Schmeda-Hirschmann G. Gastroprotective and ulcer healing effect of ferruginol in mice and rats: assessment of its mechanism of action using in vitro models. Life Sci. 78 (2006) 2503-2509
18. Areche C., Rodríguez J.A., Razmilic I., Yáñez T., Theoduloz C., and Schmeda-Hirschmann G. Gastroprotective and cytotoxic effect of semisynthetic ferruginol derivatives. J. Pharm. Phamacol. 59 (2007) 289-300
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65 (1983) 55-63
20. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 71-77
21. Hartree E.F. Determination of proteins: a modification of Lowry method that give a linear photometric response. Anal. Biochem. 48 (1972) 422-427
22. Li N., and Oberley T.D. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J. Cell Physiol. 177 (1998) 148-160
23. Chaiswing L., Bourdeau-Heller J.M., Zhong W., and Oberley T.D. Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness. Free Radic. Biol. Med. 43 (2007) 202-215
24. Chiarugi P., Taddei M.L., Schiavone N., Papucci L., Giannoni E., Fiaschi T., Capaccioli S., Raugei G., and Ramponi G. LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 23 (2004) 3905-3914
25. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., and Thun M.J. American Cancer Society Cancer statistics. Cancer J. Clin. 54 (2004) 8-29
26. Tsao A.S., Kim E.S., and Hong W.K. Chemoprevention of cancer, CA Cancer J. Clin 54 (2004) 150-180
27. Singh R.P., Dhanakakshmi S., and Agarwal R. Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancer. Cell Cycle 1 (2002) 156-161
28. Hu W., and Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 4 (2003) 721-729
29. Fulda S., and Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (2006) 4798-4811
30. D-Huang M., Guh J.-H., Huang Y.-T., Chueh S.-C., Chian P.-C., and Teng C.-M. Induction of mitotic arrest and apoptosis in human prostate cancer pc-3 cells by evodiamine. J. Urol. 173 (2005) 256-261
31. Justo G.Z., and Ferreira C.V. Coagulation and cancer therapy: the potential of natural compounds. Curr. Genomics. 6 (2005) 461-469
32. Hsu J.C., Dev A., Wing A., Brew C.T., Bjeldanes L.F., and Firestone G.L. Indole-3-carbinol mediated cell cycle arrest of LnCap human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem. Pharmacol. 72 (2006) 1714-1723
33. Gapter L., Wang Z., Glinski J., and Ng K.-Y. Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem. Biophys. Res. Commun. 332 (2005) 1153-1161
34. Solary E., Droin N., and Sordet O. Cell death pathways as targets for anticancer drugs. In: Baguley B.C., and Kerr D.J. (Eds). Anticancer Drug Development (2002), Academic Press, San Diego 55-76
35. Thornberry N., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
36. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
37. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 (1995) 505-512
38. Peter M.E., and Krammer P.H. Mechanisms of CD95 (APO-1/ Fas)-mediated apoptosis. Curr. Opin. Immunol. 10 (1998) 545-551
39. Pepper C., Hoy T., and Bently D.P. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br. J. Cancer 76 (1997) 935-938
40. Cande C., Cohen I., Daugas E., Ravagnan L., Larochette N., Zamzami N., and Kroemer G. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie. 84 (2002) 215-222
41. Sherr C.J. G1 phase progression: Cycling on cue. Cell 79 (1994) 551-555
42. Yun J.-M., Kweon M.-H., Kwon H., Hwang J.-K., and Mukhtar H. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Carcinogenesis 27 (2006) 1454-1464
43. Lim C.P., and Cao X. Structure, function, and regulation of STAT proteins. Mol. Biosyst. 2 (2006) 536-550
44. Ahonen T.J., Xie J., LeBaron M.J., Zhu J., Nurmi M., Alanen K., Rui H., and Nevalainen M.T. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. J. Biol. Chem. 278 (2003) 27287-27292
45. Barton B.E., Karras J.G., Murphy T.F., Barton A., and Huang H.F. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther. 3 (2004) 11-20
46. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., Heller R., Ellis L.M., Karras J., Bromberg J., Pardoll D., Jove R., and Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 (2002) 2000-2008
47. Rocchi P., Beraldi E., Ettinger S., Fazli L., Vessella R.L., Nelson C., and Gleave M. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res. 65 (2005) 11083-11093
48. den Hertog J., Groen A., and van der Wijk T. Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 434 (2005) 11-15
49. Ferreira C.V., Justo G.Z., Souza A.C.S., Queiroz K.C., Zambuzzi W.F., Aoyama H., and Peppelenbosch M.P. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives. Biochimie 88 (2006) 1859-1873